In this study we investigate the mRNA expression of inhibitory factor B␣ ( 
One way that the central nervous system (CNS) responds to peripheral immune challenges is by generating its own immune signal molecules (1) . The mechanisms by which this phenomenon is induced have not been elucidated. A key regulatory component of intracellular signal pathways in cells of the immune system is the nuclear factor B (NF-B)͞rel family of transcription factors. These factors respond to numerous immune challenges by activating gene transcription for a wide variety of immune signal molecules (2) . Tracing the activation of NF-B in the CNS after peripheral immune challenges may therefore reveal the extent and neuroanatomical location of the processes that are involved in responding to peripheral immune signals and, in turn, generating centrally derived immune molecules.
The mechanisms by which NF-B regulates gene expression have recently been reviewed (3) (4) (5) . Briefly, NF-B is normally present in the cytoplasm as a dormant complex with an inhibitor, IB. Upon extracellular stimulation, IB is phosphorylated and degraded. This leads to the release of free NF-B, which translocates to the nucleus and binds to specific B sequences of the DNA to initiate transcription of related genes including immunoreceptors, cytokines, and, interestingly, its own inhibitor, IB.
Two unique features of the NF-B͞IB system result from its feedback regulation. First, the activation of transcription by NF-B also triggers the synthesis of IB (4) . Second, NF-Bactivated transcription is maintained by continuous degradation of IB (5) , which is sustained by ongoing extracellular stimulation (6) . Thus, the expression of IB mRNA parallels both the NF-B activity and the duration of the activating extracellular stimulation. This temporal parallelism between IB mRNA expression and the effective external stimulation is different from other transcription factors (e.g., c-Fos) that are transiently expressed only at the onset of cellular stimulation (7) . These features may be exploited to observe the localization of cells undergoing NF-B-regulated gene transcription and infer the presence and duration of extracellular stimuli.
In this study, we measured IB␣ mRNA expression by in situ hybridization histochemistry in brain sections of rats after they were injected intraperitoneally (i.p.) with lipopolysaccharide (LPS) or sterile saline to trace the activation of responsive cells that potentially synthesize immune signal molecules in the CNS. Because LPS is a large molecule that is generally thought not to diffuse significantly across the intact blood-brain barrier (BBB) (8), we specially examined the brain levels containing areas with a leaky BBB, such as the circumventricular organs (CVOs) (9) . We selected IB␣ as a marker of NF-B activation instead of the other members of the IB family because it is ubiquitous and responds to most forms of extracellular stimulation (10) . Our results show profound LPS-induced elevation of IB␣ mRNA levels in selected cells in the CNS. The apparent migration of the observed IB␣ mRNA labeling across the BBB into deep cells of the brain suggests pathways by which peripheral LPS may activate the synthesis of immune molecules in CNS. saline alone. Animals were then killed by decapitation at 0.5, 1, 2, 4, 8, 12, and 24 hr after the injection (n ϭ 3-5 per time point). Five other groups of animals were injected intravenously (i.v.) with 1, 5, 25, or 125 g͞kg or with 2.5 mg͞kg of LPS (n ϭ 3-5 per dose) and killed 3 hr after the injection. To control for the effects due to saline injection alone, control animals that received no injection were also killed (n ϭ 3). Injections were timed so that the time of sacrifice fell between 09:00 and 13:00 hr.
Brain Section Collection. Brains were removed immediately after decapitation, frozen by immersion in 2-methyl butane at Ϫ30°C, and stored at Ϫ70°C before sectioning. They were then cryostat-cut to 15-m-thick coronal sections and thawmounted onto gelatin-coated slides, dried, and stored at Ϫ40°C until further processing. Levels collected were organum vasculosum of the lamina terminalis (OVLT) (Ϫ0.02 mm relative to bregma); subfornical organ (SFO) (Ϫ0.92 mm); central nucleus of amygdala containing also the arcuate nucleus and median eminence (Ϫ3.3 mm); and area postrema (AP) containing the nucleus of the solitary tract (NTS) (Ϫ13.7 mm) (11) .
In Situ Hybridization. The in situ hybridization protocols were performed as described previously for ribonucleotide (cRNA) probes (12) . First, tissue sections were processed by fixation with 4% formaldehyde solution, acetylation with 0.25% acetic anhydride in 0.1 M triethanolamine-HCl (pH 8.0) solution, dehydration with ethanol, and delipidation with chloroform.
Second, the antisense probes directed against the full-length (1.05 kb) rat IB␣ cDNA inserted into the pBluescript plasmid (generously provided by Rebecca Taub, University of Pennsylvania) was transcribed using the Riboprobe System (Promega) with T7 RNA polymerase and [␣-35 S]UTP (specific activity Ͼ 1,000 Ci͞mmol; New England Nuclear; 1 Ci ϭ 37 GBq) after linearization with BamHI restriction enzyme (Promega). To control for the specificity of the probe, sense probes of rat IB␣ were also generated by transcribing the same plasmid with T3 RNA polymerase after linearization with HindIII restriction enzyme (Promega). Finally, radiolabeled probes were diluted in the riboprobe hybridization buffer and applied to brain sections (500,000 cpm͞section). After overnight incubation at 55°C in a humidified chamber, slides containing brain sections were washed first in 20 g͞ml RNase solution and then in 2ϫ standard saline citrate (SSC) and 0.2ϫ SSC (55°C and 60°C) solutions to reduce nonspecific binding of the probe. The slides were then dehydrated with ethanol and air-dried for autoradiography.
Autoradiography. Slides and 14 C plastic standards containing known amounts of radioactivity (American Radiochemicals, St. Louis) were placed in x-ray cassettes, apposed to film (BioMax MR; Kodak) for 4 days, and developed in an automatic film developer (X-Omat; Kodak). To determine anatomical localization of hybridized probes at the cellular level, sections were dipped in nuclear track emulsion (NTB-2; Kodak), exposed for 2 weeks, developed (D19; Kodak) for 2 min at 16°C, and counterstained with cresyl violet.
Combined Immunohistochemistry and Hybridization Histochemistry. Four cell type-specific antibodies were used to determine the phenotypes of IB␣ mRNA-producing cells: anti-PECAM (platelet and endothelial cell adhesion molecule, generously donated to us by W. F. Hickey, Dartmouth Medical School); anti-GFAP (glial fibrillary acidic protein; ICN); OX-42 (PharMingen), and ED2 (Serotec). These antibodies specifically mark endothelial cells (13) , astrocytes, microglia, and perivascular monocytes (14) , respectively. The double labeling was carried out as follows. Fresh-frozen slidemounted brain sections were fixed in 4% formaldehyde for 15 min and rinsed three times in PBS; they were then incubated with the above primary antibodies diluted in PBS (1:400 for anti-PECAM, anti-GFAP, and ED2; 1:2000 for OX-42) for 2 hr. After three rinses in PBS, sections were incubated with the biotinylated secondary antibody (goat anti-mouse IgG, 1:200) for 1 hr, and antibody bindings were visualized by the conventional avidin-biotin immunoperoxidase protocol. These sections were then re-fixed in 4% formaldehyde, treated with 1 l͞ml proteinase K for 15 min, acetylated, and dehydrated. Subsequent localization of IB␣ mRNA by in situ hybridization was then carried out as described above.
Data Analysis. Autoradiographic film images of brain sections and standards were digitized on a Macintosh computerbased image analysis system with IMAGE software (Wayne Rasband, National Institute of Mental Health). Light transmittance through the film was measured by outlining the structure on the TV monitor. A density-slice function was applied to each structure to select densities greater than film background and thus measured transmittance confined to the cellular sources of the radioactivity. The density so obtained was used to represent the relative amount of mRNA expression of IB␣.
RESULTS
Representative film autoradiographs of IB␣ mRNA hybridization in coronally cut sections at the level of SFO are shown in Fig. 1 . No labeling was observed in any sections labeled by sense probes (data not shown). With antisense probe, only faint labeling in SFO, choroid plexus, and meninges was seen in a saline injected animal at 0.5 hr postinjection (Fig. 1 A) . The same pattern and intensity of IB␣ mRNA hybridization were found in all the saline-injected and noninjected animals (data not shown). The levels of IB␣ mRNA expression in these animals were measured by densitometry and designated as basal levels. The density of labeling measured in any other conditions will be expressed in parentheses as the percentage of these basal levels. The SEM was typically Ͻ10% of the mean levels of radioactivity.
After LPS injection, induction of IB␣ was found at several time points. At 0.5 hr, induction of IB␣ mRNA was apparent in SFO (122%), choroid plexus (287%), and large blood vessels at the base of the brain (Fig. 1B) . At 2 hr, the LPS injection induced maximal levels of IB␣ mRNA observed in this experiment (Fig. 1C) in SFO (924%) and choroid plexus (362%). In addition, meninges at the base of the brain, small penetrating blood vessels, and scattered cells inside the brain were now strongly expressing IB␣ mRNA. At 4 and 8 hr, expression levels in all the previously stimulated regions except meninges had declined to near the basal levels (data not shown). At 12 hr, IB␣ message in SFO (119%), choroid plexus (117%), and blood vessels was still just slightly above the basal levels (Fig. 1D) . A previously unaffected structure, the ventricular ependyma, by contrast, was now strongly labeled (Fig.  1D ). There was a 97% increase of hybridization signal over the basal level in these cells. The induction of IB␣ in the meningeal cells at the base of the brain persisted until this time; i.e., the labeling density was still three times the basal level, and it was three fourths of the maximal level seen at 2 hr. At 24 hr, the IB␣ expression in all the brain regions declined toward the basal levels (data not shown).
The global pattern of the induction of IB␣ mRNA at other levels, such as OVLT and central nucleus of amygdala containing median eminence, was similar to the pattern seen at SFO level; i.e., IB␣ mRNA was first induced in blood vessels, CVOs, and choroid plexus, then in cells of the meninges and brain parenchyma, and finally in ventricular ependyma while previously activated regions declined. However, two interesting differences were observed at the level of AP.
Viewed under low-power dark-field microscopy, the induction of IB␣ mRNA at the level of the AP, another CVO, is shown in emulsion-coated sections in Fig. 2 . Again, in salineinjected animals labeling was seen at low level in the AP and was not detectable in the surrounding area (basal levels, Fig.  2 A) . In the AP, IB␣ message rose at 0.5 hr, increased further at 1 hr, peaked at 2 hr, and declined to slightly above the basal level by 4 hr (Fig. 2 B-E) . At 12 hr, however, strong IB␣ labeling reappeared once again (Fig. 2F) before it subsided toward the basal level at 24 hr (data not shown). In the tissue surrounding the AP, induced IB␣ message was just detectable at 0.5 hr, became apparent in small penetrating blood vessels and in scattered small cells of the brain parenchyma at 1 hr, intensified to the maximal level in evenly distributed small cells of the brain parenchyma at 2 hr, and declined at 4 hr. At 12 hr, however, strong labeling also reappeared, but this time restricted only to small cells in the area of the NTS. Viewed under high-magnification bright-field microscopy, representative large blood vessels and the adjacent arachnoid at the base of the brain are shown in Fig. 3 . Sparse labeling was seen in saline injected animals (Fig. 3A) . At 0.5 hr, the blood vessels were intensely labeled and the message was restricted to the cells on the lumenal side of the blood vessel (Fig. 3B) . At 2 hr, IB␣ mRNA labeling was less intense over the lumen of the blood vessel, but cells of the arachnoid had become labeled (Fig. 3C) . At 12 hr, the labeling of IB␣ mRNA in the blood vessels had returned to the basal level, but the arachnoid remained labeled (Fig. 3D) . (Fig. 4A) . At 0.5 hr, cells of the choroidal blood vessels were labeled, whereas the surrounding choroidal epithelia were not (Fig. 4B) . At 2 hr, however, both blood vessels and choroidal ependyma were labeled (Fig. 4C) . Labeling declined toward the basal level thereafter (data not shown). Similarly, the IB␣ mRNA induction in various CVOs at 0.5 hr was primarily due to the induction of IB␣ mRNA in the vascular cells within the CVOs, and the later expression of IB␣ mRNA was found in cells of both the blood vessels and the CVOs proper (data not shown).
The phenotypes of cells in the brain parenchyma that express IB␣ mRNA at 2 hr after the LPS injection are illustrated in Fig. 5 . Induced IB␣ mRNA is primarily colocalized with endothelial cells (Fig. 5A ) and partially with astrocytes ( Fig. 5B ), but not with microglia (Fig. 5C ) or perivascular monocytes (Fig. 5D ). IB␣ mRNA expression was not detectable in any of these cell types in the brain parenchyma of saline-injected animals.
DISCUSSION
The results of the present study show profound induction of IB␣ mRNA in the CNS after peripheral LPS administration. Four types of responses are distinguishable. First, cells positioned at the blood side of the BBB, including those on the lumenal side of the blood vessels at the base of the brain, vascular cells of the choroid plexus and CVOs, and cells of the small penetrating blood vessels were IB␣ mRNA-positive as early as 0.5-1 hr postinjection. Second, beginning at 1 hr postinjection, endothelial cells and some astrocytes throughout the entire brain were activated, although the highest density of the IB␣ mRNA-producing cells were localized in the CVOs and choroid plexus. These two types of responses peaked at 2 hr after the LPS injection and declined thereafter.
Third, meningeal cells at the edge of the brain became strongly activated at 2 hr after the LPS injection and persisted for 10 more hours before the response was diminished. Fourth, at 12 hr after the LPS injection, while IB␣ mRNA expression in most of the brain regions declined toward the basal levels, newly activated IB␣ mRNA-expressing cells appeared in the ventricular ependyma, AP, and NTS. Taken together, the peripheral injection of LPS had induced waves of expression of IB␣ mRNA in nonneuronal cells throughout the brain, the induction pattern migrating from the cells of the BBB to cells inside of the BBB. These patterns of IkB␣ mRNA expression are also observed after either i.p. or i.v. injections of various doses LPS. The lowest effective dose of LPS was 1 g͞kg (unpublished data).
In peripheral cells, NF-B is known to trigger the expression of numerous genes in the immune system including immunoreceptors, cytokines, adhesion molecules, Rel͞NF-B members, and IB members (15) . Similarly, in dissociated cells of the CNS, NF-B has recently been shown to regulate the production of cytokines (16, 17) and immunoreceptors (18) . The observed pattern of IB␣ mRNA induction, therefore, indicates the location and time that cells in the CNS might be activated to produce these various immune signal proteins after the peripheral LPS injection, although the specific genes expressed by the activated cells are not determined.
The onset and duration of the expression of IB␣ mRNA, as discussed earlier, reflects the time course of stimulusinduced activation of NF-B-regulated gene transcription. Of the four types of stimuli currently known to activate NF-Bpathogens, mitogens, cytokines, and physical stress (3)-LPS (a pathogen and a mitogen) and the cytokines it induces are the likely activating stimuli in the present study. Therefore, the induction of IB␣ mRNA also indicates the arrival and continued presence of either LPS or cytokines in the activated brain regions. This is functionally significant because many LPS-induced centrally mediated effects such as fever (19) , prolonged slow wave sleep (20) , and altered neuroendocrine activity (21) have been attributed to the pro-inflammatory cytokines that LPS induces. Therefore, the following discussion will focus on the pathways, suggested by the present results, by which cytokines might arrive in the CNS after the LPS injection. A salient finding of the present study is the initial response after the LPS injection in cells of the cerebrovasculature. The early responsiveness of these cells may be expected because they are readily accessible by circulating LPS and cytokines. Cells inside the BBB, by contrast, are not freely accessible by blood-borne LPS (8) and cytokines [although small amounts of circulating cytokines have been reported to be transported across the BBB (22)]. In addition, receptors for LPS (23, 24) , tumor necrosis factor ␣ (25), and interleukin 1 (26) have been localized in the endothelial cells of brain vasculature. Moreover, the activation of the NF-B system in these cells suggests that they respond to the peripheral stimulation by producing their own signal molecules, probably cytokines. This is supported by our recent finding that interleukin 1␤ mRNA is rapidly synthesized in the CVOs and in brain vascular cells after peripheral LPS injection (27) .
At 2 hr after the LPS injection, many astrocytes throughout the entire brain were seen to express IB␣ mRNA. This suggests that cytokines signals have now reached brain parenchyma, and, importantly, the responsive astrocytes are probably producing centrally derived cytokines. It is noteworthy that the activation of cells in the brain proper is uniform, independent of the distance from the CVOs (comparing Fig.  2 D to F) . This is significant because it has been shown that if large molecules excluded by the BBB were to enter the brain, they will first do so at the CVOs and then diffuse slowly to the vicinity of these structures (9), displaying concentration gradients moving away from the CVOs, similar to that seen in Fig.  2F . The activation pattern we observed in the brain parenchyma at 2 hr after the LPS injection (Figs. 1C and 2D) , therefore, is not likely to be produced by LPS and cytokines that arrived by this pathway. The pattern may be best explained by cytokines that were either generated in the cells of brain blood vessels or transported from circulation across the entire BBB. Because only small amounts of certain cytokines (i.e., less than 5% of the blood levels) have been shown to be transported across the BBB (22) , it is possible that the majority of the cytokines present in CNS at 2 hr was synthesized by the earlier observed IB␣ mRNA-expressing vascular cells. Presumably, these cells secrete cytokines on their ablumenal side. Indeed, we found numerous endothelial cells expressing IkB␣ mRNA.
The highest local concentrations of IB␣ mRNA-expressing cells were seen in the CVOs, choroid plexus, and meninges at 2 hr after the LPS injection. This is probably due to the concentration of cytokine-responsive cells in these sites. For example, it has been shown that type 1 interleukin 1 receptors are highly concentrated in AP, choroid plexus, and meninges (28) . In addition, these sites may also receive stimulation by substantial amounts of peripheral cytokines because they possess a leaky BBB (9) . The present results suggest that at 2 hr after the LPS injection, the main cytokine-producing cells are located in these sites. Because the CVOs, choroid plexus, and meninges are also bathed by interstitial cerebrospinal fluid (CSF), molecules secreted from these cells will be transported by CSF flow. The persistent activation of the meningeal cells at the base of the brain after this time may result from the stimulation by cytokines flowing in the exiting subarachnoid CSF. On the other hand, cytokines secreted from these cells may also be delivered by the ventricular CSF to brain parenchyma, especially to structures in the close vicinity of the ventricle.
The finding that IB␣ mRNA was induced in cells of the ventricular ependyma at 12 hr after the peripheral LPS injection while most of the CVOs and blood vessels were no longer active is very interesting, but puzzling. Because these cells were not stimulated earlier, the extracellular stimuli that are present at 12 hr may be different from those present at earlier time points. It is not clear, however, whether these stimuli arrived from peripheral circulation or from late responsive cells of the CNS. The close vicinity of these cells to the ventricles suggests that ventricular CSF provides a functional conduit for these signal molecules.
Beyond suggesting pathways for the transduction of peripheral immune signals into the brain, the present results may have important implications for the pathogenesis of viral infections of the CNS. This is because the replication of many viruses, including HIV, are regulated by NF-B (3). It is conceivable that viral proliferation in the CNS could be facilitated when peripheral infections induce NF-B activation in the cells of the CNS similar to that seen in the present study.
